Contact – +1-276-477-5910
 Email – [email protected]

Home >>

Medical Devices & Consumables

>>

Global Drug Eluting Stents DES Market


Global Drug Eluting Stents DES Market By Type (Cobalt-chromium alloy Stents, Magnesium alloy Stents, Tyrosine polycarbonate Stents, Nitinol Stents, Platinum chromium alloy Stents, Stainless steel Stents, Other Materials) By Application (Coronary Heart Disease, Clinical) - Global Trends and Forecasts to 2025

Report code: SDMRME1457995 | Industry: Medical Devices & Consumables | Published On: 3/24/2019


Drug Eluting Stents (DES) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Drug Eluting Stents (DES) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2015-2026.

Market Segment by Type, the Drug Eluting Stents (DES) market is segmented into
Cobalt-chromium alloy Stents
Magnesium alloy Stents
Tyrosine polycarbonate Stents
Nitinol Stents
Platinum chromium alloy Stents
Stainless steel Stents
Other Materials

Market Segment by Application, the Drug Eluting Stents (DES) market is segmented into
Coronary Heart Disease
Clinical

Regional and Country-level Analysis
The Drug Eluting Stents (DES) market is analysed and market size information is provided by regions (countries).
The key regions covered in the Drug Eluting Stents (DES) market report are North America, Europe, China and Japan. It also covers key regions (countries), viz, the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of production capacity, price and revenue for the period 2015-2026.
Competitive Landscape and Drug Eluting Stents (DES) Market Share Analysis

Drug Eluting Stents (DES) market competitive landscape provides details and data information by manufacturers. The report offers comprehensive analysis and accurate statistics on production capacity, price, revenue of Drug Eluting Stents (DES) by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on production, revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue, and the production capacity, price, revenue generated in Drug Eluting Stents (DES) business, the date to enter into the Drug Eluting Stents (DES) market, Drug Eluting Stents (DES) product introduction, recent developments, etc.
The major vendors covered:
Abbott Vascular
Advantec Vascular
B.Braun Melsengen AG
Biosensors
Biotronik
Blue Medical
Boston Scientific
DISA Vascular
Essen
Medtronic Vascular
MicroPort Medical
MIV Therapeutics
Orbusneich
Promed Medical
Relisys Medical
Reva Medical
Sahajanand
Sino Medical
Sorin
Terumo Medical

Table  of  Contents
1.  Introduction

     1.1  Key  Insights
     1.2  Report  Overview
     1.3  Markets  Covered
     1.4  Stakeholders
2.  Research  Methodology
     2.1  Research  Scope
     2.2  Market  Research  Process
     2.3  Research  Data  Analysis
          2.4.1  Secondary  Research
          2.4.2  Primary  Research
          2.4.3  Models  for  Estimation
     2.5  Market  Size  Estimation
          2.5.1  Bottom-Up  Approach  -  Segmental  Market  Analysis
          2.5.2  Top-Down  Approach  -  Parent  Market  Analysis
3.  Executive  Summary
4.  Market  Overview

     4.1  Introduction
     4.2  Porter's  Five  Force  Analysis
          4.2.1  Drivers
          4.2.2  Restraints
          4.2.3  Opportunities
          4.2.4  Challenges
          
5.  Global  Drug  Eluting  Stents  DES  Market,  By  Type
     5.1  Introduction
     5.2  Cobalt-chromium  alloy  Stents,  Magnesium  alloy  Stents,  Tyrosine  polycarbonate  Stents,  Nitinol  Stents,  Platinum  chromium  alloy  Stents,  Stainless  steel  Stents,  Other  Materials
          5.2.1  Market  Overview
          5.2.2  Market  Size  and  Forecast


6.  Global  Drug  Eluting  Stents  DES  Market,  By  Application
     6.1  Introduction
     6.2  Coronary  Heart  Disease,  Clinical
          6.2.1  Market  Overview
          6.2.2  Market  Size  and  Forecast


7.  Global  Drug  Eluting  Stents  DES  Market,  By  Geography
     7.1  Introduction
     7.2  North  America
          7.2.1  North  America  Drug  Eluting  Stents  DES  Market,  By  Type
          7.2.2  North  America  Drug  Eluting  Stents  DES  Market,  By  Application
     7.3  Europe
          7.3.1  Europe  Drug  Eluting  Stents  DES  Market,  By  Type
          7.3.2  Europe  Drug  Eluting  Stents  DES  Market,  By  Application
     7.4  Asia-Pacific
          7.4.1  Asia-Pacific  Drug  Eluting  Stents  DES  Market,  By  Type
          7.4.2  Asia-Pacific  Drug  Eluting  Stents  DES  Market,  By  Application
     7.5  Rest  of  the  World
          7.5.1  Rest  of  the  World  Drug  Eluting  Stents  DES  Market  Drugs,  By  Type
          7.5.2  Rest  of  the  World  Drug  Eluting  Stents  DES  Market,  By  Application
8.  Competitive  Insights
     8.1  Key  Insights
     8.2  Company  Market  Share  Analysis
     8.3  Strategic  Outlook
          8.3.1  Mergers  &  Acquisitions
          8.3.2  New  Product  Development
          8.3.3  Portfolio/Production  Capacity  Expansions
          8.3.4  Joint  Ventures,  Collaborations,  Partnerships  &  Agreements 
          8.3.5  Others
9.  Company  Profiles
     9.1  Abbott  Vascular,  Advantec  Vascular,  B.Braun  Melsengen  AG,  Biosensors,  Biotronik,  Blue  Medical,  Boston  Scientific,  DISA  Vascular,  Essen,  Medtronic  Vascular,  MicroPort  Medical,  MIV  Therapeutics,  Orbusneich,  Promed  Medical,  Relisys  Medical,  Reva  Medical,  Sahajanand,  Sino  Medical,  Sorin,  Terumo  Medical
 


TABLE 1 Drug Eluting Stents DES Market KEY MARKET SEGMENTS IN THIS STUDY 16
TABLE 2 KEY MANUFACTURERS Drug Eluting Stents DES Market COVERED IN THIS STUDY 16
TABLE 3 GLOBAL Drug Eluting Stents DES Market MARKET SIZE GROWTH RATE BY TYPE (2018-2025) (MILLION UNITS) & (MILLION US$) 17
TABLE 4 GLOBAL Drug Eluting Stents DES Market MARKET SIZE GROWTH RATE BY APPLICATION (2018-2025) (MILLION UNITS) 20
TABLE 5 GLOBAL Drug Eluting Stents DES Market CONSUMPTION MARKET SHARE BY APPLICATION IN 2017 20
TABLE 6 GLOBAL Drug Eluting Stents DES Market MARKET SIZE GROWTH RATE BY REGIONS 2018-2025(MILLION UNITS) & (MILLION USD) 24
TABLE 7 GLOBAL MANUFACTURERS MARKET CONCENTRATION RATIO (CR5 AND HHI) 24
TABLE 8 Drug Eluting Stents DES Market MANUFACTURING BASE DISTRIBUTION AND HEADQUARTERS) 25
TABLE 9 MANUFACTURERS Drug Eluting Stents DES Market PRODUCT OFFERED 25
TABLE 10 DATE OF MANUFACTURERS ENTER INTO Drug Eluting Stents DES Market MARKET 26
TABLE 11 KEY TRENDS FOR Drug Eluting Stents DES Market MARKETS & PRODUCTS 26
TABLE 12 GLOBAL Drug Eluting Stents DES Market PRODUCTION BY MANUFACTURERS (2013-2018) (MILLION UNITS) 27
TABLE 13 GLOBAL Drug Eluting Stents DES Market PRODUCTION SHARE BY MANUFACTURERS (2013-2018) 27
TABLE 14 Drug Eluting Stents DES Market REVENUE BY MANUFACTURERS (2013-2018) (MILLION USD) 28
TABLE 15 Drug Eluting Stents DES Market REVENUE SHARE BY MANUFACTURERS (2013-2018) 29
TABLE 16 MERGERS & ACQUISITIONS, EXPANSION PLANS 29
TABLE 17 GLOBAL Drug Eluting Stents DES Market PRODUCTION BY REGIONS 2013-2018 (MILLION UNITS) 30
TABLE 18 GLOBAL Drug Eluting Stents DES Market PRODUCTION MARKET SHARE BY REGIONS 2013-2018 30
TABLE 19 GLOBAL Drug Eluting Stents DES Market REVENUE BY REGIONS 2013-2018 (MILLION USD) 32
TABLE 20 GLOBAL Drug Eluting Stents DES Market REVENUE MARKET SHARE BY REGIONS 2013-2018 32
TABLE 21 UNITED STATES Drug Eluting Stents DES Market IMPORT & EXPORT (MILLION UNITS) 35
TABLE 22 EUROPE Drug Eluting Stents DES Market IMPORT & EXPORT 37
TABLE 23 CHINA Drug Eluting Stents DES Market IMPORT & EXPORT 39
TABLE 24 JAPAN Drug Eluting Stents DES Market IMPORT & EXPORT 41
TABLE 25 SOUTH KOREA Drug Eluting Stents DES Market IMPORT & EXPORT 43
TABLE 26 GLOBAL Drug Eluting Stents DES Market CONSUMPTION BY REGIONS 2013-2018 (MILLION UNITS) 44
TABLE 27 GLOBAL Drug Eluting Stents DES Market CONSUMPTION MARKET SHARE BY REGION 2013-2018 44
TABLE 28 UNITED STATES Drug Eluting Stents DES Market CONSUMPTION BY TYPE (2013-2018) (MILLION UNITS) 46
TABLE 29 UNITED STATES Drug Eluting Stents DES Market CONSUMPTION BY APPLICATION (2013-2018) (MILLION UNITS) 47
TABLE 30 EUROPE Drug Eluting Stents DES Market CONSUMPTION BY TYPE (2013-2018) (MILLION UNITS) 49
TABLE 31 EUROPE Drug Eluting Stents DES Market CONSUMPTION BY APPLICATION (2013-2018) (MILLION UNITS) 49
TABLE 32 CHINA Drug Eluting Stents DES Market CONSUMPTION BY TYPE (2013-2018) (MILLION UNITS) 51
TABLE 33 CHINA Drug Eluting Stents DES Market CONSUMPTION BY APPLICATION (2013-2018) (MILLION UNITS) 51
TABLE 34 JAPAN Drug Eluting Stents DES Market CONSUMPTION BY TYPE (2013-2018) (MILLION UNITS) 53
TABLE 35 JAPAN Drug Eluting Stents DES Market CONSUMPTION BY APPLICATION (2013-2018) (MILLION UNITS) 53
TABLE 36 SOUTH KOREA Drug Eluting Stents DES Market CONSUMPTION BY TYPE (2013-2018) (MILLION UNITS) 55
TABLE 39 SOUTH KOREA Drug Eluting Stents DES Market CONSUMPTION BY APPLICATION (2013-2018) (MILLION UNITS) 55
TABLE 40 GLOBAL Drug Eluting Stents DES Market PRODUCTION BY TYPE (2013-2018) (MILLION UNITS) 57
TABLE 41 GLOBAL Drug Eluting Stents DES Market PRODUCTION SHARE BY TYPE (2013-2018) 57
TABLE 42 GLOBAL Drug Eluting Stents DES Market REVENUE BY TYPE (2013-2018) (MILLION USD) 59
TABLE 43 GLOBAL Drug Eluting Stents DES Market REVENUE SHARE BY TYPE (2013-2018) 59
TABLE 44 Drug Eluting Stents DES Market PRICE BY SMART LENSES013-2018 (USD/UNIT) 61
TABLE 45 GLOBAL Drug Eluting Stents DES Market CONSUMPTION BY APPLICATION (2013-2025) (MILLION UNITS) 62
TABLE 46 GLOBAL Drug Eluting Stents DES Market CONSUMPTION BY APPLICATION (2013-2018) (MILLION UNITS) 62
TABLE 47 GLOBAL Drug Eluting Stents DES Market CONSUMPTION SHARE BY APPLICATION (2013-2018) 63
TABLE 48 COMPANY 1 COMPANY DETAILS 64
TABLE 49 COMPANY 1 DESCRIPTION AND BUSINESS OVERVIEW 64
TABLE 50 COMPANY 1 Drug Eluting Stents DES Market PRODUCTION (MILLION UNITS), REVENUE (MILLION USD), PRICE (USD/UNIT) AND GROSS MARGIN (2013-2018) 65
TABLE 52 COMPANY 1 Drug Eluting Stents DES Market PRODUCT 65
TABLE 53 COMPANY 2 RECENT DEVELOPMENT 65
TABLE 54 COMPANY 2 COMPANY DETAILS 66
TABLE 55 COMPANY 3 DESCRIPTION AND BUSINESS OVERVIEW 66
TABLE 56 COMPANY 3 Drug Eluting Stents DES Market PRODUCTION (MILLION UNITS), REVENUE (MILLION USD), PRICE (USD/UNIT) AND GROSS MARGIN (2013-2018) 67
TABLE 57 COMPANY 3 Drug Eluting Stents DES Market PRODUCT 67
TABLE 58 COMPANY 3 RECENT DEVELOPMENT 67
TABLE 59 COMPANY 3 COMPANY DETAILS 68
TABLE 60 COMPANY 3 DESCRIPTION AND BUSINESS OVERVIEW 68
TABLE 61 COMPANY 3 Drug Eluting Stents DES Market PRODUCTION (MILLION UNITS), REVENUE (MILLION USD), PRICE (USD/UNIT) AND GROSS MARGIN (2013-2018) 69
TABLE 62 COMPANY 3 Drug Eluting Stents DES Market PRODUCT 69
TABLE 63 COMPANY 3 RECENT DEVELOPMENT 70
TABLE 64 COMPANY 4 COMPANY DETAILS 71
TABLE 65 COMPANY 4 DESCRIPTION AND BUSINESS OVERVIEW 71
TABLE 66 Drug Eluting Stents DES Market PRODUCTION (MILLION UNITS), REVENUE (MILLION USD), PRICE (USD/UNIT) AND GROSS MARGIN (2013-2018) 72
TABLE 67 COMPANY 4 Drug Eluting Stents DES Market PRODUCT 72
TABLE 68 COMPANY 4 RECENT DEVELOPMENT 73
TABLE 69 COMPANY 5 OPTICAL COMPANY DETAILS 73
TABLE 70 COMPANY 5 DESCRIPTION AND BUSINESS OVERVIEW 74
TABLE 71 COMPANY5 Drug Eluting Stents DES Market PRODUCTION (MILLION UNITS), REVENUE (MILLION USD), PRICE (USD/UNIT) AND GROSS MARGIN (2013-2018) 74
TABLE 72 COMPANY 5 OPTICAL Drug Eluting Stents DES Market PRODUCT 74
TABLE 73 COMPANY 5 OPTICAL RECENT DEVELOPMENT 74
TABLE 74 COMPANY 6 COMPANY DETAILS 75
TABLE 75 COMPANY 6 DESCRIPTION AND BUSINESS OVERVIEW 75
TABLE 76 COMPANY 6 Drug Eluting Stents DES Market PRODUCTION (MILLION UNITS), REVENUE (MILLION USD), PRICE (USD/UNIT) AND GROSS MARGIN (2013-2018) 76
TABLE 77 COMPANY 6 Drug Eluting Stents DES Market PRODUCT 76
TABLE 78 COMPANY 7 GLOBAL COMPANY DETAILS 77
TABLE 79 COMPANY 7 DESCRIPTION AND BUSINESS OVERVIEW 77
TABLE 80 COMPANY 7 GLOBAL Drug Eluting Stents DES Market PRODUCTION (MILLION UNITS), REVENUE (MILLION USD), PRICE (USD/UNIT) AND GROSS MARGIN (2013-2018) 77
TABLE 81 COMPANY 7 GLOBAL Drug Eluting Stents DES Market PRODUCT 78
TABLE 82 COMPANY 8 VISION COMPANY DETAILS 79
TABLE 83 COMPANY 8 DESCRIPTION AND BUSINESS OVERVIEW 79
TABLE 84 COMPANY 8 Drug Eluting Stents DES Market PRODUCTION (MILLION UNITS), REVENUE (MILLION USD), PRICE (USD/UNIT) AND GROSS MARGIN (2013-2018) 80
TABLE 85 COMPANY 8 Drug Eluting Stents DES Market PRODUCT 80
TABLE 86 COMPANY 9 COMPANY DETAILS 81
TABLE 87 COMPANY 9 DESCRIPTION AND BUSINESS OVERVIEW 81
TABLE 88 COMPANY 9 Drug Eluting Stents DES Market PRODUCTION (MILLION UNITS), REVENUE (MILLION USD), PRICE (USD/UNIT) AND GROSS MARGIN (2013-2018) 81
TABLE 89 COMPANY 9 Drug Eluting Stents DES Market PRODUCT 82
TABLE 90 COMPANY 10 COMPANY DETAILS 83
TABLE 91 COMPANY 10 DESCRIPTION AND BUSINESS OVERVIEW 83
TABLE 92 COMPANY 10 Drug Eluting Stents DES Market PRODUCTION (MILLION UNITS), REVENUE (MILLION USD), PRICE (USD/UNIT) AND GROSS MARGIN (2013-2018) 83
TABLE 93 COMPANY 10 Drug Eluting Stents DES Market PRODUCT 84
TABLE 94 GLOBAL Drug Eluting Stents DES Market REVENUE FORECAST BY REGIONS 2018-2025 (MILLION USD) 86
TABLE 95 GLOBAL Drug Eluting Stents DES Market PRODUCTION FORECAST BY REGIONS 2018-2025 (MILLION UNITS) 87
TABLE 96 GLOBAL Drug Eluting Stents DES Market PRODUCTION FORECAST BY TYPE (2018-2025) (MILLION UNITS) 94
TABLE 97 Drug Eluting Stents DES Market REVENUE FORECAST BY TYPE (2018-2025) (MILLION USD) 95
TABLE 98 GLOBAL Drug Eluting Stents DES Market CONSUMPTION FORECAST BY APPLICATION (2018-2025) (MILLION UNITS) 96
TABLE 99 GLOBAL Drug Eluting Stents DES Market CONSUMPTION FORECAST BY REGIONS 2018-2025 (MILLION UNITS) 97
TABLE 100 Drug Eluting Stents DES Market DISTRIBUTORS LIST 103
TABLE 101 KEY OPPORTUNITIES AND DRIVERS 104
TABLE 102 KEY CHALLENGES 104
TABLE 103 MARKET RISKS 104
TABLE 104 RESEARCH PROGRAMS/DESIGN FOR THIS REPORT 108
TABLE 105 KEY DATA INFORMATION FROM SECONDARY SOURCES 112
TABLE 106 KEY DATA INFORMATION FROM PRIMARY SOURCES 113
 Feel free to contact us

 
Choose License Type
Select User Type


Report code




x

Use Code

SDMR20

Purchase any report

AVAIL FLAT DISCOUNT